In Brief: Endosonics
This article was originally published in The Gray Sheet
Executive SummaryEndosonics: Company's Cardiovascular Dynamics subsidiary receives 510(k) clearance for three Bullet Hi-Flo over-the-wire catheter models indicated for delivering therapeutic solutions in treatment of coronary disease. The three models, which utilize CVD's Multiple Microporous Membrane (M3) technology, provide "different flow rates and dosage regimens" of therapeutic agents to remote locations within the heart's arteries. The Bullet catheter received FDA clearance in the fourth quarter of 1994 for peripheral vascular applications ("The Gray Sheet" Oct. 24, 1994, In Brief)...
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.